Innosign

Developer of mRNA-based diagnosis platform for precision medicine

placeEindhoven, North Brabant, Netherlands calendar_todayFounded 2021 groups16 employees language innosignbio.com

Social engagement

Social engagement: 751 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Private equity120%
Angel & family office120%

Recent activity

12 Aug 2025
Product launch
First-in-Class Portal to Identify Disease Drivers from Gene Expression Data
Coming soon